首页> 外文OA文献 >The effects of antibiotics on in-testinal microbiota and subse-quent recolonization using fecal microbiotic transplantation
【2h】

The effects of antibiotics on in-testinal microbiota and subse-quent recolonization using fecal microbiotic transplantation

机译:抗生素对肠道菌群的影响以及粪便菌群移植后的再定殖

摘要

This rapport describes how antibiotic treatment affect the human gut flora, and how a fecal micro-biotic transplantation can help recolonize the gut flora after such a treatment. The rapport explains how the gut microbiota is effected by treatments with antibiotics, and how a fecal microbiotic transplantation might help with recolonizing of the gut microbiota. To explain this, the report makes use of both reviews, academic books, and original research papers. The rapport looks at trials with antibiotic treated patients, and analyzes them. This analysis focuses on the period of recolonization for the gut flora. The trials show that treatment with antibiotics lower the diversity and changes the composition of bacteria, in the gut microbiota. Because of the lowered diversity, the gut microbiota is in a weakened state, this, in turn, affects the immune system, weakening it. This of course leaves the body susceptible to diseases until the gut flora has been recolonized. This period of recolonization varies but usually takes over a year. However it is not all patients who are able to recolonize their gut microbiota by themselves. A possible solution to this is fecal microbiotic transplantation. Since trials have shown that fecal microbiotic transplantation causes a new and more diverse microbiota very much like the one belonging to the donor. From these trials it is judged that fecal microbiotic transplantation is a method of treatment for patients not able to reestablish a balanced gut microbiota themselves. In the end, it is difficult to make a final conclusion but clear tendencies show that fecal microbiotic transplantation can help with the re-colonization of the gut microbiota.
机译:这种融洽的关系描述了抗生素治疗如何影响人类肠道菌群,以及粪便微生物移植如何在这种治疗后有助于重新定居肠道菌群。融洽的关系解释了抗生素治疗如何影响肠道菌群,以及粪便微生物菌种移植如何帮助肠道菌群重新定殖。为了对此进行解释,该报告同时使用了评论,学术书籍和原始研究论文。融洽的关系着眼于对抗生素治疗患者的试验,并对其进行分析。该分析着重于肠道菌群的重新定殖时期。试验表明,用抗生素治疗会降低肠道菌群中细菌的多样性并改变细菌的组成。由于多样性降低,肠道菌群处于弱化状态,进而影响免疫系统,使其减弱。当然,这使身体容易感染疾病,直到肠道菌群重新定殖为止。重新定殖的时间各不相同,但通常需要一年以上的时间。然而,并非所有患者都能自行重新定殖肠道菌群。一个可能的解决方案是粪便微生物移植。由于试验已经表明,粪便微生物移植会引起一种新的和更多样化的微生物群,非常类似于属于供体的微生物群。从这些试验中,可以断定粪便微生物移植是不能自己重建均衡肠道菌群的患者的治疗方法。最后,很难做出最终结论,但明确的趋势表明,粪便微生物移植可以帮助肠道菌群重新定殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号